Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Zhang Z et al. – hSSTr2 restoration mediated by oncolytic adenovirus enhances TRAIL–induced antitumor efficacy against pancreatic cancer. Combined treatment with oncolytic adenovirus–mediated hSSTr2 and TRAIL gene provides the rationale for a clinical trial in pancreatic cancer.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address